Coxiella Burnetti IgG antibody

The Coxiella Burnetti IgG antibody test detects IgG-class antibodies directed against Coxiella burnetii, the bacterium that causes Q‑fever, and is used to identify prior exposure or past infection by measuring antibody titres. Samples are collected at home by a trained phlebotomist and analysed in UAE‑accredited laboratories using validated serological methods to provide reliable quantitative results. This test is particularly important for people with animal or occupational exposure, a history of unexplained pneumonia or fever, pregnant women, and patients with cardiac valvular disease or immunosuppression where evidence of past Q‑fever may alter clinical management.

• Coxiella burnetii IgG (Phase I) titre
• Coxiella burnetii IgG (Phase II) titre
• Quantitative IgG level (reported as titre or AU/mL)

• After occupational or animal exposure with flu‑like illness or pneumonia
• Persistent unexplained fever or chronic fatigue following suspected infection
• Before initiating immunosuppressive therapy or biological agents
• When evaluating suspected chronic Q‑fever (e.g., endocarditis or vascular infection)
• In pregnancy with known exposure to livestock or unexplained febrile illness

• Convenient at‑home venous blood collection by certified phlebotomists across Dubai and the UAE
• Analysis performed in UAE‑accredited laboratories with validated serology methods
• Quantitative titres to support clinical interpretation and follow‑up decisions
• Clear, clinician‑friendly reports to share with your treating physician
• Fast sample pickup and secure result delivery through Touch Connect platform

• At‑home venous blood collection (typically 3–5 mL serum)
• No fasting required; routine medications may be continued unless advised otherwise
• Adult participants must present valid Emirates ID; minors require parental/guardian consent
• Inform the phlebotomist/ordering clinician of recent antibiotic therapy or recent acute illness